-
FEATURED CONTENT
A salmonella outbreak linked to eggs has caused 24 hospitalizations and 65 illnesses in nine states, in today's bite-sized hospital and health industry news from Georgia and Maryland.
- Georgia: Last week, CDC reported a salmonella outbreak linked to eggs sold in Illinois, Michigan, and Wisconsin. So far, the outbreak has resulted in 24 hospitalizations and 65 illnesses across nine states. Many of the affected individuals dined at the same restaurants where eggs were served. Symptoms of salmonella typically occur between six hours and six days after infection and include diarrhea, fever, and stomach cramps. Most people who are infected will recover without treatment within a week. "Some people—especially children younger than 5 years, adults 65 years and older, and people with weakened immune systems—may experience more severe illnesses that require medical treatment or hospitalization," CDC said. Currently, Milo's Poultry Farms has recalled eggs labeled with "Milo's Poultry Farms" or "Tony's Fresh Market," and consumers are advised to throw the eggs out if they have any. (Floyd, Axios, 9/7; Gregg, Washington Post, 9/9)
- Maryland: The first self-collection kits for screening cervical cancer, an alternative to Pap smears, were shipped last week. According to Axios, FDA first approved two self-collection kits for cervical cancer, one from BD and one from Roche, in May. The BD test is now available, and the Roche test will be available later in the fall. The new tests allow patients to collect their own cell samples from the vaginal walls while at a doctor's office, much like they take their own urine sample, said Jeff Andrews, VP of global medical affairs for diagnostic solutions at BD. The cost of the self-administered test will be the same as a traditional pelvic exam, and insurers will likely cover the cost since they are required to cover cervical cancer screenings. Andrews also noted that researchers are currently working on getting FDA approval for an at-home version of the test, which would allow people to be screened without going to a healthcare facility. (Goldman, Axios, 9/5)
- Maryland: FDA last week granted emergency use authorization for Novavax's updated COVID-19 vaccine. Unlike Pfizer-BioNTech's and Moderna's mRNA vaccines, which target the KP.2 strain, Novavax's protein-based vaccine targets the JN.1 strain. Individuals ages 12 and older who were previously vaccinated with an mRNA vaccine or two or more doses of the protein-based vaccine are eligible to receive Novavax's updated dose if it has been at least two months since their last dose. Individuals who have only had one dose of a Novavax vaccine can receive the updated dose at least three weeks after their last dose. Unvaccinated individuals can get two doses of the vaccine spaced three weeks apart. "The COVID-19 vaccines have had a tremendous positive impact on public health and vaccination continues to be the most effective method for COVID-19 prevention," said Peter Marks, director of the FDA's Center for Biologics Evaluation and Research. "Today's authorization provides an additional COVID-19 vaccine option that meets the FDA's standards for safety, effectiveness, and manufacturing quality needed to support emergency use authorization." (Kahn, MedPage Today, 9/3)
Don't miss out on the latest Advisory Board insights
Create your free account to access 1 resource, including the latest research and webinars.
Want access without creating an account?
You have 1 free members-only resource remaining this month.
1 free members-only resources remaining
1 free members-only resources remaining
You've reached your limit of free insights
Become a member to access all of Advisory Board's resources, events, and experts
Never miss out on the latest innovative health care content tailored to you.
Benefits include:
Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox
You've reached your limit of free insights
Become a member to access all of Advisory Board's resources, events, and experts
Never miss out on the latest innovative health care content tailored to you.Benefits include:
Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox
